These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18971283)

  • 1. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.
    Miura T; Brockman MA; Brumme ZL; Brumme CJ; Pereyra F; Trocha A; Block BL; Schneidewind A; Allen TM; Heckerman D; Walker BD
    J Virol; 2009 Jan; 83(1):140-9. PubMed ID: 18971283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
    Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
    J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.
    Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T
    Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
    Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
    J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.
    Miura T; Brockman MA; Schneidewind A; Lobritz M; Pereyra F; Rathod A; Block BL; Brumme ZL; Brumme CJ; Baker B; Rothchild AC; Li B; Trocha A; Cutrell E; Frahm N; Brander C; Toth I; Arts EJ; Allen TM; Walker BD
    J Virol; 2009 Mar; 83(6):2743-55. PubMed ID: 19116253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.
    Gijsbers EF; Feenstra KA; van Nuenen AC; Navis M; Heringa J; Schuitemaker H; Kootstra NA
    PLoS One; 2013; 8(12):e81235. PubMed ID: 24339913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.
    Brumme ZL; Li C; Miura T; Sela J; Rosato PC; Brumme CJ; Markle TJ; Martin E; Block BL; Trocha A; Kadie CM; Allen TM; Pereyra F; Heckerman D; Walker BD; Brockman MA
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):100-8. PubMed ID: 21124229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.
    Juarez-Molina CI; Payne R; Soto-Nava M; Avila-Rios S; Valenzuela-Ponce H; Adland E; Leitman E; Brener J; Muenchhoff M; Branch S; Landis C; Reyes-Teran G; Goulder P
    J Virol; 2014 Sep; 88(18):10392-8. PubMed ID: 25008926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
    Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T
    J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
    Wright JK; Novitsky V; Brockman MA; Brumme ZL; Brumme CJ; Carlson JM; Heckerman D; Wang B; Losina E; Leshwedi M; van der Stok M; Maphumulo L; Mkhwanazi N; Chonco F; Goulder PJ; Essex M; Walker BD; Ndung'u T
    J Virol; 2011 Apr; 85(8):3996-4006. PubMed ID: 21289112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
    Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
    J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
    Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
    J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of multiple Nef functions in HIV-1 elite controllers.
    Mwimanzi P; Markle TJ; Martin E; Ogata Y; Kuang XT; Tokunaga M; Mahiti M; Pereyra F; Miura T; Walker BD; Brumme ZL; Brockman MA; Ueno T
    Retrovirology; 2013 Jan; 10():1. PubMed ID: 23289738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.